New insider activity at Calumet Specialty Products ( (CLMT) ) has taken place on October 3, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
In recent transactions involving Calumet Specialty Products stock, Director Stephen P Mawer sold 2,962 shares, amounting to $46,769. Additionally, Directors John G. Boss and Daniel Sajkowski each sold 1,518 shares, with each sale valued at $23,969.
Spark’s Take on CLMT Stock
According to Spark, TipRanks’ AI Analyst, CLMT is a Neutral.
Calumet’s overall stock score is primarily impacted by its weak financial performance, which is a significant concern. While there are positive aspects such as operational improvements and strategic financial moves, the ongoing financial challenges and valuation concerns weigh heavily on the score. The technical analysis provides mixed signals, and while the earnings call and corporate events offer some optimism, they are not enough to offset the financial weaknesses.
To see Spark’s full report on CLMT stock, click here.
More about Calumet Specialty Products
YTD Price Performance: -15.37%
Average Trading Volume: 829,960
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.6B